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Abstract The heart is involved in up to 50% of all patients
with Churg–Strauss syndrome, but vasculitis of the coronary
arteries has only been rarely documented. We present a
young patient with severe coronary aneurysms and stenotic
lesions due to a Churg–Strauss vasculitis. Prompt therapy
with prednisone and cyclophosphamide resulted in the
complete resolution of all lesions.
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Introduction
The heart is involved in up to 50% of all patients with Churg–
Strauss disease [1, 2]. In contrast, vasculitis of the coronary
arteries has only been rarely documented [3–5]. Here, we
present images of repeated coronary angiography in a young
patient with Churg–Strauss syndrome demonstrating com-
plete resolution of severe coronary vasculitis after 1 year of
therapy with prednisone and cyclophosphamide.
Case report
An 18-year-old man with a history of asthma was admitted
to a local hospital because of fever, profound headache,
weight loss, red eyes, blurred vision, and generalized
muscle aches. All symptoms resolved spontaneously within
1 month before a classifying diagnosis could be made. Five
months later, the headache and blurred vision recurred, and
the patient was referred to our outpatient clinic. Laboratory
analysis at that moment revealed only mild eosinophilia
(11%; 600×106/L). Renal function was normal, and anti-
neutrophilic cytoplasmatic antibodies and anti-nuclear anti-
bodies were not present. Cranial magnetic resonance
imaging showed a unilateral thickening of the choroidal
cerebral plexus, and analysis of the cerebrospinal fluid
revealed eosinophilic meningitis. Another 3 months later,
the patient developed a persistent fever and a pulmonary
infiltrate that did not respond to antibiotics. Broncho-
alveolar lavage revealed profound eosinophilia (30%).
During admission, eosinophilic skin infiltrates and general-
ized edema developed. Now, we considered the diagnosis
of Churg–Strauss syndrome, and therapy with prednisone at
a dose of 1 mg/kg was initiated. Subsequently, the patient
developed a painful injected pharynx and chest pain, with
diffuse ST segment elevation on electrocardiography.
Echocardiopgraphy revealed a mild pericardial effusion,
without wall motion abnormalities. Intravenous gamma-
globulin (400 mg/kg per day for 5 days) was now
administered. As the chest pain recurred and there was a
rise in the plasma troponin-I concentration, a coronary
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angiography was performed. This showed multiple aneu-
rysms and stenotic lesions in all coronary arteries (Fig. 1a).
MRI scanning excluded involvement of the aorta and its
major branches. In view of the potentially fatal coronary
lesions, a more powerful immune-suppressive regimen
consisting of methylprednisolone and cyclophosphamide
(750 mg and 1,250 mg i.v. per day during 3 days, followed
by oral doses of 1 mg/kg/day prednisone, and 2 mg/kg/day
of cyclophosphamide) was chosen. The prednisone was
tapered gradually and stopped after 1 year. The cyclophos-
phamide was tapered and stopped after 16 months. A
control coronary angiography 1 year after initiation of
therapy showed a complete regression of all lesions
(Fig. 1b).
Our patient fulfilled the classification criteria of the
Churg–Strauss syndrome as established by the American
College of Rheumatology (asthma, eosinophilia, pulmonary
infiltrates, and a biopsy containing accumulation of eosino-
phils), although he also had signs and symptoms compatible
with other vasculitis syndromes, such as Kawasaki disease
(bilateral conjunctival injection, injected pharynx).
Endocardial thickening due to local infiltration of
eosinophils, which can trigger intracardial thrombus forma-
tion, is the most common presentation of heart involvement
in patients with the Churg–Strauss syndrome [1, 2].
Pericardial involvement, presenting either as an acute
pericarditis with pericardial effusion, as in our patient, or
as chronic constrictive pericarditis, has been reported in 8–
32% of patients [1]. In contrast, clinically significant
vasculitis of the coronary arteries has been reported only
anecdotically [3–5]. In general, symptomatic cardiac in-
volvement is associated with poor prognosis in patients
with medium or small vessel vasculitis and justifies a strong
and immediate immunosuppressive treatment. Indeed, the
present case report shows that therapy with prednisone and
cyclophosphamide may lead to a complete and uneventful
recovery of potentially fatal coronary artery lesions.
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Fig. 1 Left coronary angiogram in right inferior oblique view before
(a) and after (b) 1 year of immunosuppressive therapy with
prednisone and cyclophosphamide. Before the treatment, there were
two prominent aneurysms in the intermediate branch and one large
aneurysm proximally in the obtuse marginal branch (a, indicated by
white arrows) in addition to diffuse wall irregularities in all branches.
After the treatment, all these lesions have disappeared completely (b)
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